Study demonstrates feasibility of centralized data warehouse with disparate EHRs

Laura Pedulli | | Health Exec | Economics

The establishment of a national, centralized database with multiple partners and disparate EHR systems is doable, according to a study published in eGEMS (Generating Evidence & Methods to improve patient outcomes).

Researchers from Kaiser Permanente Northwest examined the development and implementation of the Community Health Applied Research Network (CHARN), a data warehouse that links 19 community health centers organized around four research specialties. CHARN includes more than 500,000 diverse safety net patients across 11 states.  

Given there is sufficient time, it is possible to develop trusting relationships between partners with varied technology, backgrounds, expertise and interest. Also, it is possible to:

  • Establish institutional, business and regulatory review processes;
  • Identify and address technical challenges in diverse data environments; and
  • Provide continuous data quality assessments.

“It is feasible, but time intensive, to create a centralized data warehouse with multiple partners using different EHR systems,” concluded the authors.

Read the paper here.

 

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.